Steve Tutewohl, Chief Operating Officer at Evolent Health, Inc. (EVH), sold 61,972 shares at $23.02 ($1.4M) on 2021-08-02, disclosed to the SEC on 2021-08-04.
Open-market sale of $1.4M EVH by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.02 | 2,625 | $60K | 4.2% |
| 2 | $23.02 | 2,625 | $60K | 4.2% |
| 3 | $23.02 | 3,331 | $77K | 5.4% |
| 4 | $23.02 | 3,331 | $77K | 5.4% |
| 5 | $23.02 | 11,229 | $258K | 18.1% |
| 6 | $23.02 | 11,229 |
| $258K |
| 18.1% |
| 7 | $23.02 | 13,801 | $318K | 22.3% |
| 8 | $23.02 | 13,801 | $318K | 22.3% |
| Total | $23.02 avg | 61,972 | $1.4M | 100% |
| Filing → |
| EVH | SELL | 2022-02-07 | $39K | — | Filing → |
| EVH | SELL | 2022-02-01 | $296K | — | Filing → |
| EVH | SELL | 2021-09-02 | $679K | — | Filing → |